Status:

UNKNOWN

Population at Risk of Malignant Hyperthermia: Ambispective Cohort.

Lead Sponsor:

Instituto de Investigación Hospital Universitario La Paz

Collaborating Sponsors:

Universidad Autonoma de Madrid

Conditions:

Hyperthermia, Malignant

Eligibility:

All Genders

Brief Summary

Malignant hyperthermia (MH) is a pharmacogenetic disease that manifests itself as a hypermetabolic response of skeletal musculature, in genetically susceptible patients, with the inhalation of volatil...

Detailed Description

Malignant hyperthermia (MH) is a pharmacogenetic disease that manifests itself as a hypermetabolic response of skeletal musculature, in genetically susceptible patients, with the inhalation of volatil...

Eligibility Criteria

Inclusion

  • Patients who have suffered at least one episode of rhabdomyolysis due to related causes in the literature with susceptibility to HM.
  • Patients who have been given information about the study and have agreed to sign the consent of the study. The muscle biopsy will be performed under usual clinical practice.

Exclusion

  • Patients who have suffered episodes of rhabdomyolysis due to alternative causes: trauma, compression hypoxia during immobilization or loss of consciousness or infectious arterial occlusion (influenza A and B, coxackievirus, Epstein-Barr, HIV, legionella, Streptococcus pyogenes Staphilococcus aureus, clostridium), metabolic or electrolyte abnormalities (hypokalemia, hypophosphatemia, hypocalcemia, non-ketosic hyperosmolar conditions, diabetic ketoacidosis), others.
  • Children under 10 years or less than 30 kg are excluded for the in vitro test (muscle biopsy).

Key Trial Info

Start Date :

February 26 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 28 2025

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT04287556

Start Date

February 26 2020

End Date

February 28 2025

Last Update

January 13 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario La Paz

Madrid, Spain, 28046